Panama City, December 23 (EFE).- The Panamanian Ministry of Health (MINSA) reported this Friday that it had authorized the emergency use of the Pfizer-BioNTech bivalent vaccine for children aged 5 to 11 years.
The bivalent vaccine targets both the original strain of the coronavirus and the omicron variant, the healthcare portfolio said in a press release.
This bivalent vaccine is authorized “as a single booster dose administered at least 2 months after completing a primary vaccination schedule with any covid-19 monovalent vaccine and receiving one of the most recent booster doses of any licensed monovalent vaccine,” explained the Minsa. .
By this same method, Minsa approved earlier this December the emergency use of Pfizer’s bivalent vaccine in people over the age of 12.
On November 29, the Panamanian Health Minister, Luis Francisco Sucre, said that steps are being taken to ensure that the mixed or bivalent vaccines arrive by the end of the year.
Panama, which is going through a sixth pandemic wave with an increase in cases and also positivity, has accumulated up to December 17 1,020,961 confirmed infections and 8,555 deaths in more than two years of the pandemic.
The Minsa has reiterated to the population the importance of maintaining self-care or biosecurity measures to avoid contagion from covid-19, such as the use of masks, physical distancing and hand washing. EFE extension
gf/mah
� EFE 2022. The redistribution and redistribution of all or part of the contents of the Efe services is expressly prohibited, without the prior and express consent of Agencia EFE SA
